Literature DB >> 7640597

Is it time to stop using chloramphenicol on the eye? Fears are based on only six cases.

R J Mulla, E Barnes, T R Rogers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640597      PMCID: PMC2550502          DOI: 10.1136/bmj.311.7002.450

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Adult pure red cell aplasia following topical ocular chloramphenicol.

Authors:  T Fernandez de Sevilla; J Alegre; T Vallespi; V Falco; J M Martinez-Vazquez
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

2.  Use of chloramphenicol as topical eye medication: time to cry halt?

Authors:  M Doona; J B Walsh
Journal:  BMJ       Date:  1995-05-13

3.  Blood dyscrasias and topical ophthalmic chloramphenicol.

Authors:  F T Fraunfelder; R L Morgan; A A Yunis
Journal:  Am J Ophthalmol       Date:  1993-06-15       Impact factor: 5.258

4.  Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol.

Authors:  F T Fraunfelder; G C Bagby; D J Kelly
Journal:  Am J Ophthalmol       Date:  1982-03       Impact factor: 5.258

  4 in total
  4 in total

Review 1.  Comparative review of topical ophthalmic antibacterial preparations.

Authors:  P Y Robert; J P Adenis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Ocular chloramphenicol and aplastic anaemia. Is there a link?

Authors:  S A Rayner; R J Buckley
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

Review 3.  Systemic adverse effects of topical ophthalmic agents. Implications for older patients.

Authors:  J P Diamond
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

4.  Possible association between ocular chloramphenicol and aplastic anaemia--the absolute risk is very low.

Authors:  J R Laporte; X Vidal; E Ballarín; L Ibáñez
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.